Ireland will lose up to €20bn in annual drugs’ exports; Pfizer to sell Lipitor as a generic drug
Nov 22nd, 2011 | By Finfacts Ireland Business & Finance Portal | Category: News worldwide
Ireland is the location of facilities of the leading American and European drug giants and the impact of the expiry of patents on many blockbuster (defined as selling at least $1bn annually) drugs is estimated to reduce Irish exports by as much as €20bn in 2014.